|
GPR183 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.59565760183523E-13 |
| Normal-vs-Stage2 |
1.85744999999793E-05 |
| Normal-vs-Stage3 |
2.76589973147168E-10 |
| Normal-vs-Stage4 |
3.27649996023638E-09 |
| Stage1-vs-Stage2 |
2.873200E-01 |
| Stage1-vs-Stage3 |
8.144800E-01 |
| Stage1-vs-Stage4 |
4.377200E-01 |
| Stage2-vs-Stage3 |
3.720400E-01 |
| Stage2-vs-Stage4 |
6.118800E-01 |
| Stage3-vs-Stage4 |
5.949800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
4.042000E-04 |
| Normal-vs-Asian |
1.425730E-02 |
| Caucasian-vs-AfricanAmerican |
5.196200E-01 |
| Caucasian-vs-Asian |
5.540400E-01 |
| AfricanAmerican-vs-Asian |
6.457400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62703184258817E-12 |
| Normal-vs-Female |
1.00109920353475E-11 |
| Male-vs-Female |
4.415600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.776000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.626032641866E-12 |
| Normal-vs-Age(61-80Yrs) |
1.20290444272086E-11 |
| Normal-vs-Age(81-100Yrs) |
9.372600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.535800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.039000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.571830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.336570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.624420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.549400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.301500E-02 |
| Normal-vs-Grade 2 |
4.10405043282935E-12 |
| Normal-vs-Grade 3 |
1.76492154224661E-12 |
| Normal-vs-Grade 4 |
1.44099999710434E-08 |
| Grade 1-vs-Grade 2 |
7.735200E-01 |
| Grade 1-vs-Grade 3 |
7.066800E-01 |
| Grade 1-vs-Grade 4 |
4.840600E-01 |
| Grade 2-vs-Grade 3 |
9.351000E-01 |
| Grade 2-vs-Grade 4 |
3.718600E-01 |
| Grade 3-vs-Grade 4 |
3.427200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.5756995708216E-10 |
| Normal-vs-ccB subtype |
1.65634173043827E-12 |
| ccA subtype-vs-ccB subtype |
1.438610E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64235292032799E-12 |
| Normal-vs-N1 |
1.883700E-02 |
| N0-vs-N1 |
4.049000E-01 |
|
|
